Product Information
MEXILETINE 150 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.2387 per EA under NDC 62756095501. Its NADAC has been published 223 times since Mar 23, 2022.
Strength
150 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756095501
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MEXILETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214089On Market Since
11/29/2021
Pharmacological Classes
Price Statistics
The NADAC for MEXILETINE 150 MG CAPSULE has been published 223 times since Mar 23, 2022, and over the history we have for it it has declined 68.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2387 per EA |
|---|---|
| All-time high | $0.7627 (Apr 13, 2022) |
| All-time low | $0.2193 (Jul 17, 2024) |
| 52-week high | $0.2727 |
| 52-week low | $0.2387 |
| Median price | $0.3306 |
| Average price | $0.3608 |
| Largest weekly change | -34.2% (Apr 17, 2024) |
| Weeks tracked | 223 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the mexiletine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MEXILETINE 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEXILETINE 150 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $0.2387 per EA (NDC 62756095501), effective Jun 24, 2026.
How has the price of MEXILETINE 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEXILETINE 150 MG CAPSULE has declined 68.7%. It has been tracked across 223 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for MEXILETINE 150 MG CAPSULE?
Since Mar 23, 2022, the NADAC for MEXILETINE 150 MG CAPSULE has ranged from a low of $0.2193 (Jul 17, 2024) to a high of $0.7627 (Apr 13, 2022), with a median of $0.3306 per EA.
Are there cheaper alternatives to MEXILETINE 150 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MEXILETINE 150 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures MEXILETINE 150 MG CAPSULE?
MEXILETINE 150 MG CAPSULE (NDC 62756095501) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification